Philip Morris International Inc shares have increased by 3.01%, reaching a 20-day high, despite the broader market decline with the Nasdaq-100 down 1.64% and the S&P 500 down 0.94%.
The rise in Philip Morris's stock is attributed to a growing investor interest in the company's Zyn oral nicotine pouches, which have gained traction in the U.S. market. This bullish sentiment comes as the company has seen a significant 44% increase in its shares over the past year, reflecting confidence in its non-cyclical defensive stock appeal amid a challenging economic environment.
This performance indicates that investors are favoring companies like Philip Morris that are innovating in the nicotine space, even as the overall consumer staples sector faces headwinds. The positive outlook on Zyn products suggests potential for continued growth and resilience in the company's stock price.
Wall Street analysts forecast PM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PM is 181.63 USD with a low forecast of 158.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast PM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PM is 181.63 USD with a low forecast of 158.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 178.880
Low
158.00
Averages
181.63
High
200.00
Current: 178.880
Low
158.00
Averages
181.63
High
200.00
Jefferies
Edward Mundy
Buy
to
Hold
downgrade
$220 -> $180
2026-01-20
Reason
Jefferies
Edward Mundy
Price Target
$220 -> $180
AI Analysis
2026-01-20
downgrade
Buy
to
Hold
Reason
Jefferies analyst Edward Mundy downgraded Philip Morris (PM) to Hold from Buy with a price target of $180, down from $220. The firm sees limited re-rating potential for the shares in 2026. Philip Morris' competitor British American Tobacco (BTI) is driving category growth in U.S. pouches and Japan Tobacco is "competing more assertively" in heated tobacco, the analyst tells investors in a research note. Jefferies sees potential downside risk to the consensus estimates for Philip Morris.
BofA
Buy
maintain
$186 -> $185
2025-12-19
Reason
BofA
Price Target
$186 -> $185
2025-12-19
maintain
Buy
Reason
BofA lowered the firm's price target on Philip Morris to $185 from $186 and keeps a Buy rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption growth and valuations remain dispersed across the group, but "there feels little to get them off the sidelines in '26 until fundamentals signal a greater turning of the tide," the analyst tells investors in a year-ahead note for the consumer staples group.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PM
Unlock Now
JPMorgan
Overweight
downgrade
$190 -> $185
2025-11-26
Reason
JPMorgan
Price Target
$190 -> $185
2025-11-26
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Philip Morris to $185 from $190 and keeps an Overweight rating on the shares.
Barclays
Gaurav Jain
Overweight
downgrade
$220 -> $180
2025-11-17
Reason
Barclays
Gaurav Jain
Price Target
$220 -> $180
2025-11-17
downgrade
Overweight
Reason
Barclays analyst Gaurav Jain lowered the firm's price target on Philip Morris to $180 from $220 and keeps an Overweight rating on the shares. The firm updated estimates post the Q3 report. It reduced Philip Morris' valuation multiple to incorporate the new ZYN competitive dynamics.
About PM
Philip Morris International Inc. is an international tobacco company. The Company’s product portfolio primarily consists of cigarettes and smoke-free products. Its smoke-free business (SFB) also includes wellness and healthcare products, as well as consumer accessories, such as lighters and matches. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and Americas Region. The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. Its IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its international cigarette brands are Chesterfield, L&M, and Philip Morris. It also owns a number of local cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia, and Fortune and Jackpot in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
